Multimodal approach to the treatment of hepatocellular carcinoma
Background. Hepatocellular carcinoma (HCC) is a malignancy of the liver associated with poor prognosis. The understanding of the prevalence of liver damage and functional status of the liver can complicate therapy in these patients and often requires non-standard treatment approach. In this context,...
Main Authors: | O G Skipenko, D A Chekunov, G A Shatverian, N N Bagmet, M I Sekacheva, R S Polyakov, A L Bedzhanyan, A G Abdullaev, Ya G Moysyuk |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IP Habib O.N.
2015-09-01
|
Series: | Современная онкология |
Subjects: | |
Online Access: | https://modernonco.orscience.ru/1815-1434/article/view/27029 |
Similar Items
-
Invasive methods of hepatocellular carcinoma treatment
by: Gulziya Ismailova, et al.
Published: (2017-12-01) -
Diffuse Recurrence of Hepatocellular Carcinoma After Liver Resection: Transarterial Chemoembolization (TACE) Combined With Sorafenib Versus TACE Monotherapy
by: Wang Yao, et al.
Published: (2020-12-01) -
Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma
by: Jun Young Kim, et al.
Published: (2016-06-01) -
Role of drug-eluting beads versus conventional transarterial chemoembolization in the treatment of hepatocellular carcinoma
by: Mahmoud Abu Elfadl, et al.
Published: (2019-01-01) -
Role of triphasic computed tomography in prediction of response to transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma patients
by: Ahmed A.E Hassan Desoky, et al.
Published: (2019-01-01)